Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > BioSante Pharmaceuticals to Present at the Susquehanna Healthcare Conference

Abstract:
BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) today announced that Stephen M. Simes, its president and CEO, will present a corporate update and overview at the Susquehanna Financial Group's Second Annual Healthcare Conference, at the W Hotel in New York City. Mr. Simes will present on Wednesday March 5, 2008 at 11:30 a.m. local time. The Susquehanna Conference will feature more than 50 companies presenting to institutional investors, portfolio managers and analysts interested in the biotechnology and pharmaceuticals sectors.

BioSante Pharmaceuticals to Present at the Susquehanna Healthcare Conference

LINCOLNSHIRE, IL | Posted on March 4th, 2008

A live audio webcast of BioSante's presentation at the Susquehanna Conference may be accessed at www.biosantepharma.com/Webcasts.php and a replay will be available at the same link for 60 days.

####

About BioSante Pharmaceuticals, Inc.
BioSante is developing a pipeline of hormone therapy products to treat both men and women. These hormone therapy products are gel formulations for transdermal administration that deliver estradiol and testosterone. BioSante's lead products include LibiGel® (transdermal testosterone gel) in Phase III clinical development by BioSante under a U.S. Food and Drug Administration (FDA) SPA (Special Protocol Assessment) for the treatment of female sexual dysfunction (FSD), and Elestrin™ (estradiol gel) developed through FDA approval by BioSante, indicated for the treatment of moderate-to-severe vasomotor symptoms associated with menopause, marketed in the U.S. by Nycomed US, BioSante's licensee. Also in development are Bio-T-Gel™, a testosterone gel for male hypogonadism, and an oral contraceptive in Phase II clinical development using BioSante patented technology. The current market in the U.S. for estrogen and testosterone products is approximately $2.5 billion and for oral contraceptives approximately $3.0 billion. The company also is developing its calcium phosphate nanotechnology (CaP) for novel vaccines, drug delivery and aesthetic medicine (BioLook™).

For more information, please click here

Contacts:
McKinney/Chicago
Alan Zachary
(312) 944-6784 ext. 316

www.mckinneychicago.com

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Lifeboat Foundation Responds to Largest Ebola Outbreak in History October 2nd, 2014

Iran's Sharif University to Host 4th Conference on Nanostructured Solar Cells October 2nd, 2014

Multifunctional Cotton Fabrics Produced in Iran Using Nanotechnology October 2nd, 2014

Graphene chips are close to significant commercialization October 1st, 2014

Nanomedicine

Arrowhead Expands Management Team with Appointment of Susan Boynton as Vice President Global Regulatory Affairs October 1st, 2014

Nanobotmodels present metastasis and angiogenesis medical animation October 1st, 2014

'Stealth' nanoparticles could improve cancer vaccines October 1st, 2014

New Absorber Will Lead to Better Biosensor: Biosensors are more sensitive and able to detect smaller changes in the environment October 1st, 2014

Announcements

Lifeboat Foundation Responds to Largest Ebola Outbreak in History October 2nd, 2014

Iran's Sharif University to Host 4th Conference on Nanostructured Solar Cells October 2nd, 2014

Multifunctional Cotton Fabrics Produced in Iran Using Nanotechnology October 2nd, 2014

Graphene chips are close to significant commercialization October 1st, 2014

Events/Classes

Iran's Sharif University to Host 4th Conference on Nanostructured Solar Cells October 2nd, 2014

Yale University and Leica Microsystems Partner to Establish Microscopy Center of Excellence: Yale Welcomes Scientists to Participate in Core Facility Opening and Super- Resolution Workshops October 20 Through 31, 2014 September 30th, 2014

Oxford Instruments launches 3rd annual Indian nanotechnology seminars in Kolkata and Delhi - sharing expertise with Nanotechnology researchers in India September 25th, 2014

Grenoble Hosting SEMICON Europa Oct. 7-9, First Time Event Held in France: Leti’s 90-square-meter Booth Will Feature Portable Showroom To Demonstrate New Technology Innovations September 24th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE